Catalyst Wire Dossier Catalyst Wire Dossier

long-acting insulins (three types unspecified)

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for long-acting insulins (three types unspecified), covering 2023-11-02 to 2023-11-02. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins [Phase 4]

See pricing